A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Incyte Corporation
Chengdu Zenitar Biomedical Technology Co., Ltd
Prescient Therapeutics, Ltd.
Seagen Inc.
Soligenix
Treeline Biosciences, Inc.
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
Kyowa Kirin Co., Ltd.
Boston Immune Technologies and Therapeutics
Bio-Path Holdings, Inc.
Daiichi Sankyo
Eisai Inc.
BeiGene
Takeda
4SC AG
Mundipharma Research Limited
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Eisai Inc.
Genmab
OncoSec Medical Incorporated
Genmab
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Genzada Pharmaceuticals USA, Inc.
Elorac, Inc.
Sorrento Therapeutics, Inc.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Merck Sharp & Dohme LLC
Soligenix
miRagen Therapeutics, Inc.
Alexion Pharmaceuticals, Inc.
4SC AG
Cyclacel Pharmaceuticals, Inc.
AbbVie
Eisai Inc.
Galderma R&D
Innate Pharma
Takeda
miRagen Therapeutics, Inc.
miRagen Therapeutics, Inc.
Eli Lilly and Company
Seagen Inc.
Helsinn Therapeutics (U.S.), Inc
Rhizen Pharmaceuticals SA
Acrotech Biopharma Inc.